首页 > 最新文献

Acta Biomaterialia最新文献

英文 中文
A cross-linked coating loaded with antimicrobial peptides for corrosion control, early antibacterial, and sequential osteogenic promotion on a magnesium alloy as orthopedic implants 含抗菌肽的交联涂层在镁合金矫形植入物上的腐蚀控制、早期抗菌和顺序成骨促进作用。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-02-01 DOI: 10.1016/j.actbio.2024.12.046
Hao Zhang , Peng Zhang , Xiaolong Shen , Jiaping Han , Haibo Wang , Haotian Qin , Binbin Wang , Junyu Qian , Anjaneyulu Udduttula , Rifang Luo , Kexin Zhao , Yunbing Wang , Yingqi Chen
Magnesium (Mg)-based alloys have been recognized as desirable biodegradable materials for orthopedic implants. However, their clinical application has been limited by rapid degradation rates, insufficient antibacterial and osteogenic-promotion properties. Herein, a MgF2 priming layer was first constructed on AZ31 surface. Then, dopamine and polyphenols (EGCG) were cross-linked onto this AZ31-F surface to promote osteogenesis and further enhance corrosion protection, followed by chemical grafting of antimicrobial peptides (AMPs) via Michael-addition and Schiff-base reaction to confer antibacterial properties. In vitro electrochemical corrosion tests showed that icorr of AZ31-FE/AMPs (4.36×10−7 A/cm2) is two orders of magnitude lower than that of AZ31 (4.17×10−5 A/cm2). In vitro immersion degradation showed that AZ31-FE/AMPs exhibited the lowest hydrogen release (2.38 mL) after 400 h immersion with the lowest hydrogen evolution rate among them. Further, AZ31-FE/AMPs displayed inhibitory effects against S. aureus and E. coil in the initial stage and even after 7 days immersion in PBS (antibacterial rate > 85 %). AZ31-FE/AMPs promoted ALP secretion and calcium nodule formation in MC3T3-E1 cells. Transcriptome sequencing results indicated that osteogenic promotion mechanism of AZ31-FE/AMPs in MC3T3-E1 may involve the PI3K-Akt signalling pathway. Further, AZ31-FE/AMPs enhanced new bone formation when implanted in a rat femoral bone defect model. This coating strategy addresses initial antibacterial and later osteogenesis needs based on the corrosion control, which is crucial for the surface design of Mg-based implants.

Statement of significance

It is critical for magnesium-based orthopedic implants to achieve sequential functions in the bone repair process while controlling an appropriate degradation rate. A MgF2 priming layer/phenolic-amine grafted AMPs (antimicrobial peptides) duplex coating was constructed on AZ31 surface in this study. The MgF2 layer provided a basic corrosion protection to magnesium substrate, and dopamine and polyphenols (EGCG) were then cross-linked to the MgF2 pretreated AZ31 to promote osteogenesis and enhance corrosion resistance, followed by chemical grafting of AMPs to confer antibacterial property. This strategy effectively meets the initial need for infection resistance and later osteogenic promotion on the basis of controlling the substrate corrosion rate, thus holding significant implications for the surface design of magnesium-based implants.
镁基合金已被认为是一种理想的可生物降解骨科植入材料。然而,它们的临床应用受到降解速度快、抗菌和促进成骨性能不足的限制。本文首先在AZ31表面构建了MgF2引射层。然后,多巴胺和多酚(EGCG)交联到AZ31-F表面,促进成骨,进一步增强腐蚀保护,然后通过迈克尔加成和希夫碱反应化学接枝抗菌肽(amp),赋予抗菌性能。体外电化学腐蚀试验表明,AZ31- fe / amp的icorr (4.36×10-7 A/cm2)比AZ31的icorr (4.17 10-5 A/cm2)低2个数量级。体外浸渍降解结果表明,AZ31-FE/ amp浸泡400 h后释氢量最低(2.38 mL),释氢速率最低。此外,AZ31-FE/AMPs在初始阶段甚至在PBS浸泡7天后都表现出对金黄色葡萄球菌和E. coil的抑制作用(抑菌率bb0 85%)。AZ31-FE/ amp促进MC3T3-E1细胞ALP分泌和钙结节形成。转录组测序结果表明,MC3T3-E1中AZ31-FE/ amp促进成骨的机制可能涉及PI3K-Akt信号通路。此外,AZ31-FE/ amp在大鼠股骨骨缺损模型中植入后,促进了新骨的形成。这种涂层策略解决了基于腐蚀控制的初始抗菌和后期成骨需求,这对镁基植入物的表面设计至关重要。意义声明:镁基骨科植入物在骨修复过程中实现顺序功能,同时控制适当的降解率是至关重要的。本研究在AZ31表面构建了MgF2引物层/酚醛胺接枝抗菌肽双涂层。MgF2层为镁基质提供基本的腐蚀保护,然后将多巴胺和多酚(EGCG)交联到MgF2预处理的AZ31上,以促进成骨和增强耐腐蚀性,然后化学接枝AMPs以获得抗菌性能。该策略在控制基体腐蚀速率的基础上,有效地满足了初期抗感染和后期促进成骨的需要,因此对镁基种植体的表面设计具有重要意义。
{"title":"A cross-linked coating loaded with antimicrobial peptides for corrosion control, early antibacterial, and sequential osteogenic promotion on a magnesium alloy as orthopedic implants","authors":"Hao Zhang ,&nbsp;Peng Zhang ,&nbsp;Xiaolong Shen ,&nbsp;Jiaping Han ,&nbsp;Haibo Wang ,&nbsp;Haotian Qin ,&nbsp;Binbin Wang ,&nbsp;Junyu Qian ,&nbsp;Anjaneyulu Udduttula ,&nbsp;Rifang Luo ,&nbsp;Kexin Zhao ,&nbsp;Yunbing Wang ,&nbsp;Yingqi Chen","doi":"10.1016/j.actbio.2024.12.046","DOIUrl":"10.1016/j.actbio.2024.12.046","url":null,"abstract":"<div><div>Magnesium (Mg)-based alloys have been recognized as desirable biodegradable materials for orthopedic implants. However, their clinical application has been limited by rapid degradation rates, insufficient antibacterial and osteogenic-promotion properties. Herein, a MgF<sub>2</sub> priming layer was first constructed on AZ31 surface. Then, dopamine and polyphenols (EGCG) were cross-linked onto this AZ31-F surface to promote osteogenesis and further enhance corrosion protection, followed by chemical grafting of antimicrobial peptides (AMPs) via Michael-addition and Schiff-base reaction to confer antibacterial properties. <em>In vitro</em> electrochemical corrosion tests showed that <em>i<sub>corr</sub></em> of AZ31-FE/AMPs (4.36×10<sup>−7</sup> A/cm<sup>2</sup>) is two orders of magnitude lower than that of AZ31 (4.17×10<sup>−5</sup> A/cm<sup>2</sup>). <em>In vitro</em> immersion degradation showed that AZ31-FE/AMPs exhibited the lowest hydrogen release (2.38 mL) after 400 h immersion with the lowest hydrogen evolution rate among them. Further, AZ31-FE/AMPs displayed inhibitory effects against <em>S. aureus</em> and <em>E. coil</em> in the initial stage and even after 7 days immersion in PBS (antibacterial rate &gt; 85 %). AZ31-FE/AMPs promoted ALP secretion and calcium nodule formation in MC3T3-E1 cells. Transcriptome sequencing results indicated that osteogenic promotion mechanism of AZ31-FE/AMPs in MC3T3-E1 may involve the PI3K-Akt signalling pathway. Further, AZ31-FE/AMPs enhanced new bone formation when implanted in a rat femoral bone defect model. This coating strategy addresses initial antibacterial and later osteogenesis needs based on the corrosion control, which is crucial for the surface design of Mg-based implants.</div></div><div><h3>Statement of significance</h3><div>It is critical for magnesium-based orthopedic implants to achieve sequential functions in the bone repair process while controlling an appropriate degradation rate. A MgF<sub>2</sub> priming layer/phenolic-amine grafted AMPs (antimicrobial peptides) duplex coating was constructed on AZ31 surface in this study. The MgF<sub>2</sub> layer provided a basic corrosion protection to magnesium substrate, and dopamine and polyphenols (EGCG) were then cross-linked to the MgF<sub>2</sub> pretreated AZ31 to promote osteogenesis and enhance corrosion resistance, followed by chemical grafting of AMPs to confer antibacterial property. This strategy effectively meets the initial need for infection resistance and later osteogenic promotion on the basis of controlling the substrate corrosion rate, thus holding significant implications for the surface design of magnesium-based implants.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"193 ","pages":"Pages 604-622"},"PeriodicalIF":9.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dually fluorinated unimolecular micelles for stable oxygen-carrying and enhanced photosensitive efficiency to boost photodynamic therapy against hypoxic tumors 双氟化单分子胶束稳定载氧和增强光敏效率,促进光动力治疗缺氧肿瘤。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-02-01 DOI: 10.1016/j.actbio.2025.01.017
Shunhu Zhang , Nailin Yang , Shumin Sun , Haitao Zhao , Wenxuan Wang , Jihu Nie , Zifan Pei , Weiwei He , Lifen Zhang , Liang Cheng , Zhenping Cheng
Tumor hypoxia is one of key challenges in deep tumor photodynamic therapy (PDT), and how to fix this issue is attracting ongoing concerns worldwide. This work demonstrates dually fluorinated unimolecular micelles with desirable and stable oxygen-carrying capacity, high cellular penetration, and integrative type I & II PDT for deep hypoxic tumors. Dually fluorinated star copolymers with fluorinated phthalocyanines as the core are prepared through photoinitiated electron/energy transfer-reversible addition-fragmentation chain transfer (PET-RAFT) polymerization under irradiation with NIR LED light at room temperature, followed by assembly into unimolecular micelles. Perfluorocarbons (PFCs) are also introduced into the star polymers during the polymerization to further enhance and stabilize oxygen-carrying capacity, which is slightly affected by concentration-induced size transformation. PFCs assist unimolecular micelles with repelling mucin adsorption, which results in superior cellular uptake within 1 h and high effective accumulation rates in tumors of CT26 tumor-bearing mice within 24 h after systemic administration, and showing effective anti-tumor effects under the irradiation of NIR LED light. This work provides a new type of nano-photosensitizers for highly efficient hypoxic PDT.

Statement of significance

One of the major challenges in improving the efficiency of photodynamic therapy (PDT) for deep tumors is how to address tumor hypoxia, which is receiving continued attention worldwide. However, most of the reported oxygen carriers combine with photosensitizers by physical means and the carriers have the risk of dissociating easily, which is not conducive to long-term and efficient PDT, resulting in poor therapeutic effect. This work demonstrates dually fluorinated unimolecular micelles with desirable and stable oxygen-carrying capacity, high cellular penetration, and integrative type I & II PDT for enhanced deep hypoxic tumors, overcoming the key challenges of tumor hypoxia and low photosensitizer efficiency.
肿瘤缺氧是深部肿瘤光动力疗法(PDT)面临的主要挑战之一,如何解决这一问题正受到全世界的持续关注。这项工作展示了具有理想和稳定携氧能力、高细胞穿透性的双氟化单分子胶束,以及针对深部缺氧肿瘤的 I 型和 II 型综合光动力疗法。以氟化酞菁为核心的双氟星型共聚物是在室温下用近红外 LED 光照射,通过光引发电子/能量转移-可逆加成-断裂链转移(PET-RAFT)聚合反应制备的,然后组装成单分子胶束。在聚合过程中,还将全氟化碳(PFCs)引入星形聚合物,以进一步提高和稳定载氧能力,这种能力会受到浓度诱导的尺寸变化的轻微影响。PFCs 可帮助单分子胶束排斥粘蛋白的吸附,从而在 1 小时内获得优异的细胞吸收率,并在全身给药后 24 小时内在 CT26 肿瘤小鼠的肿瘤中获得较高的有效蓄积率,在近红外 LED 光照射下显示出有效的抗肿瘤效果。这项工作为高效缺氧光导疗法提供了一种新型纳米光敏剂。意义声明:提高深部肿瘤光动力疗法(PDT)效率的主要挑战之一是如何解决全球持续关注的肿瘤缺氧问题。然而,目前报道的大多数氧载体都是通过物理方法与光敏剂结合,载体存在易解离的风险,不利于长期、高效的光动力疗法,导致治疗效果不佳。这项工作展示了具有理想和稳定载氧能力、高细胞穿透性的二重氟化单分子胶束,以及用于增强深部缺氧性肿瘤的 I 型和 II 型综合光导疗法,克服了肿瘤缺氧和光敏剂效率低的关键难题。
{"title":"Dually fluorinated unimolecular micelles for stable oxygen-carrying and enhanced photosensitive efficiency to boost photodynamic therapy against hypoxic tumors","authors":"Shunhu Zhang ,&nbsp;Nailin Yang ,&nbsp;Shumin Sun ,&nbsp;Haitao Zhao ,&nbsp;Wenxuan Wang ,&nbsp;Jihu Nie ,&nbsp;Zifan Pei ,&nbsp;Weiwei He ,&nbsp;Lifen Zhang ,&nbsp;Liang Cheng ,&nbsp;Zhenping Cheng","doi":"10.1016/j.actbio.2025.01.017","DOIUrl":"10.1016/j.actbio.2025.01.017","url":null,"abstract":"<div><div>Tumor hypoxia is one of key challenges in deep tumor photodynamic therapy (PDT), and how to fix this issue is attracting ongoing concerns worldwide. This work demonstrates dually fluorinated unimolecular micelles with desirable and stable oxygen-carrying capacity, high cellular penetration, and integrative type I &amp; II PDT for deep hypoxic tumors. Dually fluorinated star copolymers with fluorinated phthalocyanines as the core are prepared through photoinitiated electron/energy transfer-reversible addition-fragmentation chain transfer (PET-RAFT) polymerization under irradiation with NIR LED light at room temperature, followed by assembly into unimolecular micelles. Perfluorocarbons (PFCs) are also introduced into the star polymers during the polymerization to further enhance and stabilize oxygen-carrying capacity, which is slightly affected by concentration-induced size transformation. PFCs assist unimolecular micelles with repelling mucin adsorption, which results in superior cellular uptake within 1 h and high effective accumulation rates in tumors of CT26 tumor-bearing mice within 24 h after systemic administration, and showing effective anti-tumor effects under the irradiation of NIR LED light. This work provides a new type of nano-photosensitizers for highly efficient hypoxic PDT.</div></div><div><h3>Statement of significance</h3><div>One of the major challenges in improving the efficiency of photodynamic therapy (PDT) for deep tumors is how to address tumor hypoxia, which is receiving continued attention worldwide. However, most of the reported oxygen carriers combine with photosensitizers by physical means and the carriers have the risk of dissociating easily, which is not conducive to long-term and efficient PDT, resulting in poor therapeutic effect. This work demonstrates dually fluorinated unimolecular micelles with desirable and stable oxygen-carrying capacity, high cellular penetration, and integrative type I &amp; II PDT for enhanced deep hypoxic tumors, overcoming the key challenges of tumor hypoxia and low photosensitizer efficiency.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"193 ","pages":"Pages 406-416"},"PeriodicalIF":9.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular endothelial cells derived from transgene-free pig induced pluripotent stem cells for vascular tissue engineering 无转基因猪诱导多能干细胞衍生的血管内皮细胞用于血管组织工程。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-02-01 DOI: 10.1016/j.actbio.2024.12.033
Luke Batty , Jinkyu Park , Lingfeng Qin , Muhammad Riaz , Yuyao Lin , Zhen Xu , Xuefei Gao , Xin Li , Colleen Lopez , Wei Zhang , Marie Hoareau , Meghan E. Fallon , Yan Huang , Hangqi Luo , Jiesi Luo , Séverine Ménoret , Peining Li , Zhenting Jiang , Peter Smith , David H. Sachs , Yibing Qyang
Induced pluripotent stem cells (iPSCs) hold great promise for the treatment of cardiovascular diseases through cell-based therapies, but these therapies require extensive preclinical testing that is best done in species-in-species experiments. Pigs are a good large animal model for these tests due to the similarity of their cardiovascular system to humans. However, a lack of adequate pig iPSCs (piPSCs) that are analogous to human iPSCs has greatly limited the potential usefulness of this model system. Herein, transgene-free piPSCs with true pluripotency were generated by using reprogramming factors in an optimized pig pluripotency medium. Using an effective differentiation protocol, piPSCs were used to derive endothelial cells (ECs) which displayed EC markers and functionality comparable to native pig ECs. Further, piPSC-ECs demonstrated suitability for vascular tissue engineering, producing a tissue engineered vascular conduit (TEVC) that displayed the upregulation of flow responding markers. In an in vivo functional study, these piPSC-EC-TEVCs maintained the expression of endothelial markers and prevented thrombosis as interposition inferior vena cava grafts in immunodeficient rats. The piPSCs described in this study open up the possibility of unique preclinical species-in-species large animal modeling for the furtherance of modeling of cell-based cardiovascular tissue engineering therapies.

Statement of Significance

While there has been significant progress in the development of cellularized cardiovascular tissue engineered therapeutics using stem cells, few of them have moved into clinical trials. This is due to the lack of a robust preclinical large animal model to address the high safety and efficacy standards for transplanted therapeutics. In this study, pig stem cells that are analagous to human's were created to address this bottleneck. They demonstrated the ability to differentiate into functional endothelial cells and were able to create a tissue engineered therapeutic that is analogous to a human therapy. With these cells, future experiments testing the safety and efficacy of tissue engineered constructs are possible, bringing these crucial therapeutics closer to the patients that need them.
诱导多能干细胞(iPSCs)在通过细胞疗法治疗心血管疾病方面具有很大的前景,但这些疗法需要广泛的临床前测试,最好在物种间实验中进行。猪是一个很好的大型动物模型,因为它们的心血管系统与人类相似。然而,缺乏足够的类似于人类iPSCs的猪iPSCs (piPSCs)极大地限制了该模型系统的潜在用途。本研究通过在优化的猪多能性培养基中使用重编程因子生成了具有真正多能性的无转基因pipsc。使用有效的分化方案,piPSCs被用于衍生内皮细胞(ECs),其显示EC标记和功能与天然猪ECs相当。此外,piPSC-ECs证明了血管组织工程的适用性,产生了组织工程血管导管(TEVC),显示了流量响应标记的上调。在一项体内功能研究中,这些pipsc - ec - tevc维持了内皮标志物的表达,并作为插入性下腔静脉移植物在免疫缺陷大鼠中预防血栓形成。本研究中描述的pipsc为促进基于细胞的心血管组织工程治疗的建模开辟了独特的种中种大型动物临床前建模的可能性。重要性声明:虽然使用干细胞的细胞化心血管组织工程疗法的发展取得了重大进展,但其中很少进入临床试验。这是由于缺乏一个强大的临床前大型动物模型来解决移植治疗的高安全性和有效性标准。在这项研究中,创造了与人类相似的猪干细胞来解决这一瓶颈。他们展示了分化为功能性内皮细胞的能力,并能够创造一种类似于人类治疗的组织工程治疗方法。有了这些细胞,未来测试组织工程结构的安全性和有效性的实验成为可能,使这些关键的治疗方法更接近需要它们的患者。
{"title":"Vascular endothelial cells derived from transgene-free pig induced pluripotent stem cells for vascular tissue engineering","authors":"Luke Batty ,&nbsp;Jinkyu Park ,&nbsp;Lingfeng Qin ,&nbsp;Muhammad Riaz ,&nbsp;Yuyao Lin ,&nbsp;Zhen Xu ,&nbsp;Xuefei Gao ,&nbsp;Xin Li ,&nbsp;Colleen Lopez ,&nbsp;Wei Zhang ,&nbsp;Marie Hoareau ,&nbsp;Meghan E. Fallon ,&nbsp;Yan Huang ,&nbsp;Hangqi Luo ,&nbsp;Jiesi Luo ,&nbsp;Séverine Ménoret ,&nbsp;Peining Li ,&nbsp;Zhenting Jiang ,&nbsp;Peter Smith ,&nbsp;David H. Sachs ,&nbsp;Yibing Qyang","doi":"10.1016/j.actbio.2024.12.033","DOIUrl":"10.1016/j.actbio.2024.12.033","url":null,"abstract":"<div><div>Induced pluripotent stem cells (iPSCs) hold great promise for the treatment of cardiovascular diseases through cell-based therapies, but these therapies require extensive preclinical testing that is best done in species-in-species experiments. Pigs are a good large animal model for these tests due to the similarity of their cardiovascular system to humans. However, a lack of adequate pig iPSCs (piPSCs) that are analogous to human iPSCs has greatly limited the potential usefulness of this model system. Herein, transgene-free piPSCs with true pluripotency were generated by using reprogramming factors in an optimized pig pluripotency medium. Using an effective differentiation protocol, piPSCs were used to derive endothelial cells (ECs) which displayed EC markers and functionality comparable to native pig ECs. Further, piPSC-ECs demonstrated suitability for vascular tissue engineering, producing a tissue engineered vascular conduit (TEVC) that displayed the upregulation of flow responding markers. In an <em>in vivo</em> functional study, these piPSC-EC-TEVCs maintained the expression of endothelial markers and prevented thrombosis as interposition inferior vena cava grafts in immunodeficient rats. The piPSCs described in this study open up the possibility of unique preclinical species-in-species large animal modeling for the furtherance of modeling of cell-based cardiovascular tissue engineering therapies.</div></div><div><h3>Statement of Significance</h3><div>While there has been significant progress in the development of cellularized cardiovascular tissue engineered therapeutics using stem cells, few of them have moved into clinical trials. This is due to the lack of a robust preclinical large animal model to address the high safety and efficacy standards for transplanted therapeutics. In this study, pig stem cells that are analagous to human's were created to address this bottleneck. They demonstrated the ability to differentiate into functional endothelial cells and were able to create a tissue engineered therapeutic that is analogous to a human therapy. With these cells, future experiments testing the safety and efficacy of tissue engineered constructs are possible, bringing these crucial therapeutics closer to the patients that need them.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"193 ","pages":"Pages 171-184"},"PeriodicalIF":9.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142840551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active and passive material response of urinary bladder smooth muscle tissue in uniaxial and biaxial tensile testing 膀胱平滑肌组织在单轴和双轴拉伸试验中的主动和被动物质反应。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-02-01 DOI: 10.1016/j.actbio.2024.12.045
Julian Geldner , Stefan Papenkort , Simon Kiem , Markus Böl , Tobias Siebert
The urinary bladder is a hollow organ that undergoes significant deformation as it receives, stores, and releases urine. To understand the organ mechanics, it is necessary to obtain information about the material properties of the tissues involved. In displacement-controlled tensile tests, tissue samples are mounted on a device that applies stretches to the tissue in one or more directions, resulting in a specific stress response. For this study, we performed uniaxial and biaxial stretch experiments on tissue samples (n = 36) from the body region of the porcine urinary bladder. We analyzed the stress-relaxation, activation dynamics, and passive and active stretch-stress response. Main findings of our experiments are: (1) For uniaxial and biaxial stretching, the time constants for stress-relaxation depend on the stretch amplitude, (2) biaxially stretched samples experienced slower activation with τact increasing by +63% compared to uniaxial stretching, (3) biaxial tests are characterized by reduced optimum stretches λopt by -18%, and (4) biaxial and uniaxial tests showed no significant difference in maximum active stresses σopt. To interpret the results, we present a continuum mechanical model based on a viscoelastic, isotropic solid extended by a set of active muscle fibers. Model predictions show that results (3) and (4) can be explained by a uniform distribution of fiber orientations and a specific shape of the active fiber stress-stretch relationship. This study highlights how deformation modes during tensile testing affects smooth muscle mechanics, proving insights for interpreting experimental data and improving organ modeling.

Statement of Significance

In this study, we examined the mechanical properties of porcine bladder smooth muscle using uniaxial and equibiaxial tensile tests. To our knowledge, this is the first instance where the active stress-stretch relationships of smooth muscle tissue have been analysed under equibiaxial stretch. The data collected offer a detailed understanding of the connection between deformation and active stress production, surpassing the insights provided by existing uniaxial tests in the literature. These findings are crucial for comprehending the physiology of smooth muscle tissue and for developing constitutive muscle models that can make more accurate predictions about the functionality of hollow organs in both health and disease. Additionally, our findings on smooth muscle active stress could aid in the creation of biomaterials that interact with or even replace natural muscle.
膀胱是一个中空的器官,当它接收、储存和释放尿液时,会发生明显的变形。为了理解器官力学,有必要获得有关相关组织的材料特性的信息。在位移控制拉伸试验中,将组织样品安装在向一个或多个方向对组织施加拉伸的装置上,从而产生特定的应力响应。在这项研究中,我们对猪膀胱身体区域的组织样本(n = 36)进行了单轴和双轴拉伸实验。我们分析了应力-松弛、激活动力学以及被动和主动拉伸-应力响应。实验结果表明:(1)单轴拉伸和双轴拉伸试样的应力松弛时间常数与拉伸幅度有关;(2)双轴拉伸试样的活化速度较慢,τact比单轴拉伸增大163%;(3)双轴拉伸试样的最佳拉伸量λopt减小-18%;(4)双轴和单轴拉伸试样的最大活性应力σopt无显著差异。为了解释结果,我们提出了一个基于粘弹性的连续力学模型,各向同性固体由一组活动肌纤维延伸。模型预测表明,结果(3)和(4)可以用纤维取向的均匀分布和活性纤维应力-拉伸关系的特定形状来解释。这项研究强调了拉伸测试中的变形模式如何影响平滑肌力学,为解释实验数据和改进器官建模提供了见解。意义声明:在这项研究中,我们使用单轴和等双轴拉伸试验检测了猪膀胱平滑肌的力学性能。据我们所知,这是平滑肌组织在等双轴拉伸下主动应力-拉伸关系分析的第一个实例。收集的数据提供了对变形和主动应力产生之间联系的详细了解,超越了文献中现有单轴试验提供的见解。这些发现对于理解平滑肌组织的生理机能和开发组成肌模型至关重要,这些模型可以更准确地预测健康和疾病中空心器官的功能。此外,我们关于平滑肌主动应激的发现可以帮助创造与天然肌肉相互作用甚至取代天然肌肉的生物材料。
{"title":"Active and passive material response of urinary bladder smooth muscle tissue in uniaxial and biaxial tensile testing","authors":"Julian Geldner ,&nbsp;Stefan Papenkort ,&nbsp;Simon Kiem ,&nbsp;Markus Böl ,&nbsp;Tobias Siebert","doi":"10.1016/j.actbio.2024.12.045","DOIUrl":"10.1016/j.actbio.2024.12.045","url":null,"abstract":"<div><div>The urinary bladder is a hollow organ that undergoes significant deformation as it receives, stores, and releases urine. To understand the organ mechanics, it is necessary to obtain information about the material properties of the tissues involved. In displacement-controlled tensile tests, tissue samples are mounted on a device that applies stretches to the tissue in one or more directions, resulting in a specific stress response. For this study, we performed uniaxial and biaxial stretch experiments on tissue samples (<em>n</em> = 36) from the body region of the porcine urinary bladder. We analyzed the stress-relaxation, activation dynamics, and passive and active stretch-stress response. Main findings of our experiments are: (1) For uniaxial and biaxial stretching, the time constants for stress-relaxation depend on the stretch amplitude, (2) biaxially stretched samples experienced slower activation with <span><math><msub><mi>τ</mi><mrow><mi>a</mi><mi>c</mi><mi>t</mi></mrow></msub></math></span> increasing by +63% compared to uniaxial stretching, (3) biaxial tests are characterized by reduced optimum stretches <span><math><msub><mi>λ</mi><mrow><mi>o</mi><mi>p</mi><mi>t</mi></mrow></msub></math></span> by -18%, and (4) biaxial and uniaxial tests showed no significant difference in maximum active stresses <span><math><msub><mi>σ</mi><mi>opt</mi></msub></math></span>. To interpret the results, we present a continuum mechanical model based on a viscoelastic, isotropic solid extended by a set of active muscle fibers. Model predictions show that results (3) and (4) can be explained by a uniform distribution of fiber orientations and a specific shape of the active fiber stress-stretch relationship. This study highlights how deformation modes during tensile testing affects smooth muscle mechanics, proving insights for interpreting experimental data and improving organ modeling.</div></div><div><h3>Statement of Significance</h3><div>In this study, we examined the mechanical properties of porcine bladder smooth muscle using uniaxial and equibiaxial tensile tests. To our knowledge, this is the first instance where the active stress-stretch relationships of smooth muscle tissue have been analysed under equibiaxial stretch. The data collected offer a detailed understanding of the connection between deformation and active stress production, surpassing the insights provided by existing uniaxial tests in the literature. These findings are crucial for comprehending the physiology of smooth muscle tissue and for developing constitutive muscle models that can make more accurate predictions about the functionality of hollow organs in both health and disease. Additionally, our findings on smooth muscle active stress could aid in the creation of biomaterials that interact with or even replace natural muscle.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"193 ","pages":"Pages 255-266"},"PeriodicalIF":9.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca2+ trapping 骨肉瘤靶向PtIV前药两亲体通过Ca2+诱捕增强化学免疫治疗。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-02-01 DOI: 10.1016/j.actbio.2024.12.048
Jianqin Yan, Dengshuai Wei, Zijian Zhao, Kaichuang Sun, Yong Sun
Platinum (PtII)-based anticancer agents exhibit a lack of selectivity in the treatment of osteosarcoma, resulting in significant toxicity. Furthermore, immune surveillance withinthe tumor microenvironment impedes the uptake of platinum drugs by osteosarcoma cells. To overcome these challenges, an oxaliplatin-based PtIV prodrug amphiphile (Lipo-OXA-ALN) was designed and synthesized by incorporatingan osteosarcoma-targeting alendronate (ALN) alongside a lipid tail. The lipid nanoparticles (ALN-OXA), which self-assemble from Lipo-OXA-ALN, enhanced intracellular platinum uptake due to their superior Ca2+ trapping ability and significantly inhibit osteosarcoma cell activity. Moreover, ALN-OXA exhibited potent targeting capabilities, effectively suppressing osteosarcoma growth while preventing bone destruction. Importantly, ALN-OXA induces a series of immune responses characterized by the activation of immune cells, maturation of dendritic cells, and secretion of related cytokines, followed by the activation and infiltration of T lymphocytes and a significant increase in the ratio of cytotoxic T cells. Additionally, the ratio of M1/M2 macrophages increased markedly after ALN-OXA treatment, suggesting potential reprogramming of the tumor microenvironment by ALN-OXA. Overall, the improved therapeutic efficacy against osteosarcoma demonstrates that the PtIV prodrug amphiphile represents a promising strategy for combining targeted chemotherapy with strategies aimed at reversing immune suppression.

Statement of significance

Platinum (PtII)-based chemotherapy for osteosarcoma faces challenges due to poor tumor selectivity, leading to suboptimal efficacy and increased toxicity. Additionally, the osteosarcoma microenvironment impedes effective drug delivery. To overcome these limitations, we developed an oxaliplatin-based PtIV prodrug nanoparticle (ALN-OXA) for targeted chemo-immunotherapy. ALN-OXA showed significant in vivo efficacy, effectively preventing bone damage and enhancing the immune microenvironment to improve treatment outcomes. This innovative approach not only targets the tumor more efficiently but also boosts immune response, offering a promising strategy for tumor blockade, tumor starvation, and other therapeutic applications in osteosarcoma treatment.
基于铂(PtII)的抗癌药物在骨肉瘤治疗中缺乏选择性,导致显著的毒性。此外,肿瘤微环境中的免疫监视阻碍了骨肉瘤细胞对铂类药物的摄取。为了克服这些挑战,设计并合成了一种基于奥沙利铂的PtIV前药两亲性药物(lipoo - oxa -ALN),通过将靶向骨肉瘤的阿仑膦酸钠(ALN)与脂质尾部结合。脂质纳米颗粒(ALN-OXA)由脂质- oxa - aln自组装而成,由于其优越的Ca2+捕获能力,增强了细胞内铂的摄取,并显著抑制了骨肉瘤细胞的活性。此外,ALN-OXA表现出强大的靶向能力,有效抑制骨肉瘤生长,同时防止骨破坏。重要的是,ALN-OXA诱导了一系列免疫反应,其特征是免疫细胞的激活、树突状细胞的成熟和相关细胞因子的分泌,随后是T淋巴细胞的激活和浸润,细胞毒性T细胞的比例显著增加。此外,ALN-OXA治疗后,M1/M2巨噬细胞比例显著增加,提示ALN-OXA可能对肿瘤微环境进行重编程。总的来说,骨肉瘤治疗效果的提高表明PtIV前药两亲性药物代表了一种有希望的靶向化疗与旨在逆转免疫抑制的策略相结合的策略。意义声明:基于铂(PtII)的骨肉瘤化疗由于肿瘤选择性差而面临挑战,导致疗效不佳和毒性增加。此外,骨肉瘤微环境阻碍了有效的药物递送。为了克服这些限制,我们开发了一种基于奥沙利铂的PtIV前药纳米颗粒(ALN-OXA)用于靶向化学免疫治疗。ALN-OXA在体内表现出显著的疗效,可有效预防骨损伤,增强免疫微环境,改善治疗效果。这种创新的方法不仅能更有效地靶向肿瘤,还能增强免疫反应,为骨肉瘤的肿瘤阻断、肿瘤饥饿和其他治疗应用提供了一种有前途的策略。
{"title":"Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca2+ trapping","authors":"Jianqin Yan,&nbsp;Dengshuai Wei,&nbsp;Zijian Zhao,&nbsp;Kaichuang Sun,&nbsp;Yong Sun","doi":"10.1016/j.actbio.2024.12.048","DOIUrl":"10.1016/j.actbio.2024.12.048","url":null,"abstract":"<div><div>Platinum (Pt<sup>II</sup>)-based anticancer agents exhibit a lack of selectivity in the treatment of osteosarcoma, resulting in significant toxicity. Furthermore, immune surveillance withinthe tumor microenvironment impedes the uptake of platinum drugs by osteosarcoma cells. To overcome these challenges, an oxaliplatin-based Pt<sup>IV</sup> prodrug amphiphile (Lipo-OXA-ALN) was designed and synthesized by incorporatingan osteosarcoma-targeting alendronate (ALN) alongside a lipid tail. The lipid nanoparticles (ALN-OXA), which self-assemble from Lipo-OXA-ALN, enhanced intracellular platinum uptake due to their superior Ca<sup>2+</sup> trapping ability and significantly inhibit osteosarcoma cell activity. Moreover, ALN-OXA exhibited potent targeting capabilities, effectively suppressing osteosarcoma growth while preventing bone destruction. Importantly, ALN-OXA induces a series of immune responses characterized by the activation of immune cells, maturation of dendritic cells, and secretion of related cytokines, followed by the activation and infiltration of T lymphocytes and a significant increase in the ratio of cytotoxic T cells. Additionally, the ratio of M1/M2 macrophages increased markedly after ALN-OXA treatment, suggesting potential reprogramming of the tumor microenvironment by ALN-OXA. Overall, the improved therapeutic efficacy against osteosarcoma demonstrates that the Pt<sup>IV</sup> prodrug amphiphile represents a promising strategy for combining targeted chemotherapy with strategies aimed at reversing immune suppression.</div></div><div><h3>Statement of significance</h3><div>Platinum (Pt<sup>II</sup>)-based chemotherapy for osteosarcoma faces challenges due to poor tumor selectivity, leading to suboptimal efficacy and increased toxicity. Additionally, the osteosarcoma microenvironment impedes effective drug delivery. To overcome these limitations, we developed an oxaliplatin-based Pt<sup>IV</sup> prodrug nanoparticle (ALN-OXA) for targeted chemo-immunotherapy. ALN-OXA showed significant <em>in vivo</em> efficacy, effectively preventing bone damage and enhancing the immune microenvironment to improve treatment outcomes. This innovative approach not only targets the tumor more efficiently but also boosts immune response, offering a promising strategy for tumor blockade, tumor starvation, and other therapeutic applications in osteosarcoma treatment.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"193 ","pages":"Pages 474-483"},"PeriodicalIF":9.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142886557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell confinement by micropatterning induces phenotypic changes in cancer-associated fibroblasts 微模式化的细胞隔离诱导癌症相关成纤维细胞的表型改变。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-01-15 DOI: 10.1016/j.actbio.2024.12.007
Aleksandr Mitriashkin , Josephine Yu Yan Yap , Elekuttige Anton Kanishka Fernando , N. Gopalakrishna Iyer , Gianluca Grenci , Eliza Li Shan Fong
Recent advances in single-cell studies have revealed the vast transcriptomic heterogeneity of cancer-associated fibroblasts (CAFs), with each subset likely having unique roles in the tumor microenvironment. However, it is still unclear how different CAF subsets should be cultured in vitro to recapitulate their in vivo phenotype. The inherent plasticity of CAFs, or their ability to dynamically change their phenotype in response to different environmental stimuli, makes it highly challenging to induce and maintain a specific CAF state in vitro. In this study, we investigated how cell shape and confinement on two-dimensional culture substrates with different stiffnesses influence CAF transcriptomic profile and phenotype. Using micropatterning of polyacrylamide hydrogels to induce shape- and confinement-dependent changes in cell morphology, we observed that micropatterned CAFs exhibited phenotypic shifts towards more desmoplastic and inflammatory CAF subsets. Additionally, micropatterning enabled control over a range of CAF-specific markers and pathways. Lastly, we report how micropatterned and non-micropatterned CAFs respond differently to anti-cancer drugs, highlighting the importance of phenotype-oriented therapy that considers for CAF plasticity and regulatory networks. Control over CAF morphology offers a unique opportunity to establish highly robust CAF phenotypes in vitro, facilitating deeper understanding of CAF plasticity, heterogeneity, and development of novel therapeutic targets.

Statement of significance

Cancer-associated fibroblasts (CAFs) are the dominant stromal cell type in many cancers, and recent studies have revealed that they are highly heterogeneous and comprise several subpopulations. It is still unclear how different subsets of CAFs should be cultured in vitro to recapitulate their in vivo phenotype. In this study, we investigated how cell shape and confinement affect CAF transcriptomic profile and phenotype. We report that micropatterned CAFs resemble desmoplastic and inflammatory CAF subsets observed in vivo and respond differently to anti-cancer drugs as compared to non-patterned CAFs. Control over CAF morphology enables the generation of highly robust CAF phenotypes in vitro, facilitating deeper understanding of CAF plasticity and heterogeneity.
单细胞研究的最新进展揭示了癌症相关成纤维细胞(CAFs)的巨大转录组异质性,每个亚群可能在肿瘤微环境中具有独特的作用。然而,目前尚不清楚不同的CAF亚群应该如何在体外培养以重现其体内表型。CAF固有的可塑性,即它们在不同环境刺激下动态改变表型的能力,使得在体外诱导和维持特定的CAF状态极具挑战性。在这项研究中,我们研究了细胞形状和限制在不同刚度的二维培养基质上对CAF转录组谱和表型的影响。利用聚丙烯酰胺水凝胶的微图型诱导细胞形态的形状和限制依赖性变化,我们观察到微图型CAF表现出向更多的结缔组织增生和炎症性CAF亚群的表型转变。此外,微模式还可以控制一系列的caf特异性标记物和通路。最后,我们报告了微图案和非微图案的CAF对抗癌药物的不同反应,强调了考虑CAF可塑性和调节网络的表型导向治疗的重要性。对CAF形态的控制为在体外建立高度稳健的CAF表型提供了一个独特的机会,有助于更深入地了解CAF的可塑性、异质性和开发新的治疗靶点。意义声明:癌症相关成纤维细胞(CAFs)是许多癌症中主要的基质细胞类型,最近的研究表明它们是高度异质性的,包括几个亚群。目前尚不清楚不同的caf亚群应该如何在体外培养以重现其体内表型。在这项研究中,我们研究了细胞形状和限制如何影响CAF转录组谱和表型。我们报道,微模式CAF类似于在体内观察到的结缔组织增生和炎性CAF亚群,与非模式CAF相比,对抗癌药物的反应不同。对CAF形态的控制可以在体外产生高度稳健的CAF表型,从而有助于更深入地了解CAF的可塑性和异质性。
{"title":"Cell confinement by micropatterning induces phenotypic changes in cancer-associated fibroblasts","authors":"Aleksandr Mitriashkin ,&nbsp;Josephine Yu Yan Yap ,&nbsp;Elekuttige Anton Kanishka Fernando ,&nbsp;N. Gopalakrishna Iyer ,&nbsp;Gianluca Grenci ,&nbsp;Eliza Li Shan Fong","doi":"10.1016/j.actbio.2024.12.007","DOIUrl":"10.1016/j.actbio.2024.12.007","url":null,"abstract":"<div><div>Recent advances in single-cell studies have revealed the vast transcriptomic heterogeneity of cancer-associated fibroblasts (CAFs), with each subset likely having unique roles in the tumor microenvironment. However, it is still unclear how different CAF subsets should be cultured <em>in vitro</em> to recapitulate their <em>in vivo</em> phenotype. The inherent plasticity of CAFs, or their ability to dynamically change their phenotype in response to different environmental stimuli, makes it highly challenging to induce and maintain a specific CAF state <em>in vitro</em>. In this study, we investigated how cell shape and confinement on two-dimensional culture substrates with different stiffnesses influence CAF transcriptomic profile and phenotype. Using micropatterning of polyacrylamide hydrogels to induce shape- and confinement-dependent changes in cell morphology, we observed that micropatterned CAFs exhibited phenotypic shifts towards more desmoplastic and inflammatory CAF subsets. Additionally, micropatterning enabled control over a range of CAF-specific markers and pathways. Lastly, we report how micropatterned and non-micropatterned CAFs respond differently to anti-cancer drugs, highlighting the importance of phenotype-oriented therapy that considers for CAF plasticity and regulatory networks. Control over CAF morphology offers a unique opportunity to establish highly robust CAF phenotypes <em>in vitro</em>, facilitating deeper understanding of CAF plasticity, heterogeneity, and development of novel therapeutic targets.</div></div><div><h3>Statement of significance</h3><div>Cancer-associated fibroblasts (CAFs) are the dominant stromal cell type in many cancers, and recent studies have revealed that they are highly heterogeneous and comprise several subpopulations. It is still unclear how different subsets of CAFs should be cultured <em>in vitro</em> to recapitulate their <em>in vivo</em> phenotype. In this study, we investigated how cell shape and confinement affect CAF transcriptomic profile and phenotype. We report that micropatterned CAFs resemble desmoplastic and inflammatory CAF subsets observed <em>in vivo</em> and respond differently to anti-cancer drugs as compared to non-patterned CAFs. Control over CAF morphology enables the generation of highly robust CAF phenotypes <em>in vitro</em>, facilitating deeper understanding of CAF plasticity and heterogeneity.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"192 ","pages":"Pages 61-76"},"PeriodicalIF":9.4,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bio-functional niobium-based metallic biomaterials: Exploring their physicomechanical properties, biological significance, and implant applications 生物功能铌基金属生物材料:探索其物理机械特性、生物意义和植入应用。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-01-15 DOI: 10.1016/j.actbio.2024.12.036
Ziyuan Liu , Ming-Chun Zhao , Dengfeng Yin , Ying-Chao Zhao , Andrej Atrens
The significance of biomedical applications of bio-functional niobium (Nb)-based metallic biomaterials is underscored by their potential utilization in implant application. Nb-based metallic materials present reliable physicomechanical and biological properties, thus represent materials highly suitable for implant application. This review provides an overview on the advances of pure niobium and Nb-based metallic materials as implant materials over the past 20 years, and highlights the advantages of Nb-based metallic biomaterials for implant application in terms of their physicomechanical properties, corrosion resistance in biological media, magnetic resonance imaging (MRI) compatibility, cell compatibility, blood compatibility, osteogenesis, and bioactivity. An introduction is provided for the production and processing techniques for Nb-based metallic biomaterials, including traditional melting processes like vacuum arc remelting, additive manufacturing like selective laser melting (SLM), electron beam melting (EBM), spark plasma sintering (SPS), and severe plastic deformation like equal channel angular pressing (ECAP), multi-axial forging (MAF), high pressure torsion (HPT), as well as their physicomechanical properties and implant application. Also suggested are the critical issues, challenges, and prospects in the further development of Nb-based metallic biomaterials for implant applications.

Statement of significance

Nb-based biomaterials have gained significant interest for bioimplantable scaffolds because of their appropriate mechanical characteristics and biocompatibility. No prior work has been published specifically reviewing bio-functional Nb-based biomaterials for exploring their physicomechanical properties, biological significance, and implant applications. This review provides an overview on the advances of niobium and Nb-based materials as implant materials over the past 20 years, and highlights the advantages of Nb-based biomaterials for implant application. An introduction is provided for the production and processing techniques for Nb-based biomaterials, as well as their physicomechanical properties and implant application. Also suggested are the critical issues, challenges, and prospects in the further development of Nb-based biomaterials for implant applications.
生物功能铌(Nb)基金属生物材料在生物医学方面的应用,因其在植入应用中的潜在用途而显得尤为重要。铌基金属材料具有可靠的物理机械和生物特性,因此是非常适合植入应用的材料。本综述概述了纯铌和铌基金属材料作为植入材料在过去 20 年中取得的进展,并重点介绍了铌基金属生物材料在植入应用中的物理机械性能、生物介质中的耐腐蚀性、磁共振成像(MRI)兼容性、细胞兼容性、血液兼容性、成骨和生物活性等方面的优势。本文介绍了铌基金属生物材料的生产和加工技术,包括真空电弧重熔等传统熔化工艺,选择性激光熔化(SLM)、电子束熔化(EBM)、火花等离子烧结(SPS)等快速成型制造工艺,等通道角压(ECAP)、多轴锻造(MAF)、高压扭转(HPT)等严重塑性变形工艺,以及它们的物理机械性能和植入应用。此外,还提出了进一步开发用于植入应用的铌基金属生物材料的关键问题、挑战和前景。意义说明:铌基生物材料因其适当的机械特性和生物相容性,在生物植入支架方面获得了极大的关注。目前还没有专门针对生物功能铌基生物材料的综述,以探讨其物理机械特性、生物意义和植入应用。本综述概述了铌和铌基材料作为植入材料在过去 20 年中取得的进展,并强调了铌基生物材料在植入应用中的优势。文章介绍了铌基生物材料的生产和加工技术,以及它们的物理力学性能和植入应用。此外,还提出了进一步开发用于植入应用的铌基生物材料的关键问题、挑战和前景。
{"title":"Bio-functional niobium-based metallic biomaterials: Exploring their physicomechanical properties, biological significance, and implant applications","authors":"Ziyuan Liu ,&nbsp;Ming-Chun Zhao ,&nbsp;Dengfeng Yin ,&nbsp;Ying-Chao Zhao ,&nbsp;Andrej Atrens","doi":"10.1016/j.actbio.2024.12.036","DOIUrl":"10.1016/j.actbio.2024.12.036","url":null,"abstract":"<div><div>The significance of biomedical applications of bio-functional niobium (Nb)-based metallic biomaterials is underscored by their potential utilization in implant application. Nb-based metallic materials present reliable physicomechanical and biological properties, thus represent materials highly suitable for implant application. This review provides an overview on the advances of pure niobium and Nb-based metallic materials as implant materials over the past 20 years, and highlights the advantages of Nb-based metallic biomaterials for implant application in terms of their physicomechanical properties, corrosion resistance in biological media, magnetic resonance imaging (MRI) compatibility, cell compatibility, blood compatibility, osteogenesis, and bioactivity. An introduction is provided for the production and processing techniques for Nb-based metallic biomaterials, including traditional melting processes like vacuum arc remelting, additive manufacturing like selective laser melting (SLM), electron beam melting (EBM), spark plasma sintering (SPS), and severe plastic deformation like equal channel angular pressing (ECAP), multi-axial forging (MAF), high pressure torsion (HPT), as well as their physicomechanical properties and implant application. Also suggested are the critical issues, challenges, and prospects in the further development of Nb-based metallic biomaterials for implant applications.</div></div><div><h3>Statement of significance</h3><div>Nb-based biomaterials have gained significant interest for bioimplantable scaffolds because of their appropriate mechanical characteristics and biocompatibility. No prior work has been published specifically reviewing bio-functional Nb-based biomaterials for exploring their physicomechanical properties, biological significance, and implant applications. This review provides an overview on the advances of niobium and Nb-based materials as implant materials over the past 20 years, and highlights the advantages of Nb-based biomaterials for implant application. An introduction is provided for the production and processing techniques for Nb-based biomaterials, as well as their physicomechanical properties and implant application. Also suggested are the critical issues, challenges, and prospects in the further development of Nb-based biomaterials for implant applications.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"192 ","pages":"Pages 1-27"},"PeriodicalIF":9.4,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142840549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stimuli-responsive hydrogel microspheres encapsulated with tumor-cell-derived microparticles for malignant ascites treatment 包裹有肿瘤细胞衍生微颗粒的刺激响应型水凝胶微球用于恶性腹水治疗。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-01-15 DOI: 10.1016/j.actbio.2024.11.034
Shishi Zhu , Xin Shou , Gaizhen Kuang , Xiuyan Kong , Weijian Sun , Qingfei Zhang , Jinglin Xia
Tumor-cell-derived microparticles (TMPs) have been recognized as chemotherapeutic drug carriers and immunomodulators for anti-tumor therapy. Research in the clinical application of TMPs has been devoted to developing an effective delivery formulation that could enhance their therapeutic effects. Here, we propose thermal-responsive agarose hydrogel microspheres (MTX-TMPs@MSs) with encapsulation of Methotrexate (MTX)-packaging TMPs (MTX-TMPs) and black phosphorus quantum dots (BPQDs) by microfluidic technology for synergistic treatment of malignant ascites. The laden MTX-TMPs, separated from apoptotic tumor cells, could target tumor cells for the delivery of chemotherapy drugs and modulate the tumor immune microenvironment. Under near-infrared (NIR) induced thermal stimulation, MTX-TMPs could be controllably released from the low-melting-point agarose matrix hydrogel microspheres for chemotherapy (CHT) and immunotherapy (IMT). In addition, benefiting from photothermal therapy (PTT)-induced tumor immunogenic death, the anti-tumor immune response triggered by MTX-TMPs was further enhanced. Based on these features, the MTX-TMPs@MSs could remarkably eliminate tumor cells in vitro and obviously suppress tumor growth in vivo through synergistic PTT, CHT, and IMT. Therefore, it is envisaged that this TMPs-integrated microcarrier will have promising applications in clinical tumor therapy.

Statement of Significance

Primary liver cancer ranks third among the causes of cancer deaths globally, with hepatocellular carcinoma (HCC) being the most common type. In particular, patients with advanced HCC accompanied by malignant ascites, a common complication, indicate tumor metastasis and a poor prognosis. In this paper, we developed stimuli-responsive hydrogel microspheres from microfluidics for the delivery of methotrexate (MTX)-loaded tumor-cell-derived microparticles (MTX-TMPs) for synergistic chemotherapy, photothermal therapy, and immunotherapy. The release of MTX-TMPs from hydrogel microspheres could be on-demand controlled through BPQDs-mediated photothermal stimulus. On the other hand, BPQDs-mediated mild hyperthermia cooperatesss with MTX-TMPs-induced chemotherapy could participate in remodeling the tumor immunosuppressive microenvironment. Thus, the prepared microcarrier system holds great promise for tumor therapy.
肿瘤细胞衍生微颗粒(TMPs)已被视为抗肿瘤治疗的化疗药物载体和免疫调节剂。TMPs 的临床应用研究一直致力于开发一种有效的给药配方,以增强其治疗效果。在此,我们提出了一种热响应琼脂糖水凝胶微球(MTX-TMPs@MSs),通过微流控技术封装了甲氨蝶呤(MTX)包裹的TMPs(MTX-TMPs)和黑磷量子点(BPQDs),用于协同治疗恶性腹水。从凋亡肿瘤细胞中分离出来的MTX-TMPs载体可以靶向肿瘤细胞递送化疗药物,并调节肿瘤免疫微环境。在近红外(NIR)热刺激下,MTX-TMPs 可从低熔点琼脂糖基质水凝胶微球中可控地释放出来,用于化疗(CHT)和免疫治疗(IMT)。此外,得益于光热疗法(PTT)诱导的肿瘤免疫原性死亡,MTX-TMPs 引发的抗肿瘤免疫反应得到了进一步增强。基于这些特点,MTX-TMPs@MSs 可在体外显著消除肿瘤细胞,并通过 PTT、CHT 和 IMT 的协同作用在体内明显抑制肿瘤生长。因此,这种 TMPs 集成微载体有望在临床肿瘤治疗中得到应用。意义说明:原发性肝癌在全球癌症死亡原因中排名第三,其中肝细胞癌(HCC)是最常见的类型。尤其是伴有恶性腹水这一常见并发症的晚期 HCC 患者,预示着肿瘤转移和不良预后。在本文中,我们利用微流控技术开发了刺激响应型水凝胶微球,用于递送甲氨蝶呤(MTX)负载的肿瘤细胞衍生微颗粒(MTX-TMPs),以协同化疗、光热疗法和免疫疗法。通过 BPQDs 介导的光热刺激,可按需控制 MTX-TMPs 从水凝胶微球中的释放。另一方面,BPQDs 介导的温和热疗与 MTX-TMPs 诱导的化疗配合使用,可参与重塑肿瘤免疫抑制微环境。因此,制备的微载体系统在肿瘤治疗中大有可为。
{"title":"Stimuli-responsive hydrogel microspheres encapsulated with tumor-cell-derived microparticles for malignant ascites treatment","authors":"Shishi Zhu ,&nbsp;Xin Shou ,&nbsp;Gaizhen Kuang ,&nbsp;Xiuyan Kong ,&nbsp;Weijian Sun ,&nbsp;Qingfei Zhang ,&nbsp;Jinglin Xia","doi":"10.1016/j.actbio.2024.11.034","DOIUrl":"10.1016/j.actbio.2024.11.034","url":null,"abstract":"<div><div>Tumor-cell-derived microparticles (TMPs) have been recognized as chemotherapeutic drug carriers and immunomodulators for anti-tumor therapy. Research in the clinical application of TMPs has been devoted to developing an effective delivery formulation that could enhance their therapeutic effects. Here, we propose thermal-responsive agarose hydrogel microspheres (MTX-TMPs@MSs) with encapsulation of Methotrexate (MTX)-packaging TMPs (MTX-TMPs) and black phosphorus quantum dots (BPQDs) by microfluidic technology for synergistic treatment of malignant ascites. The laden MTX-TMPs, separated from apoptotic tumor cells, could target tumor cells for the delivery of chemotherapy drugs and modulate the tumor immune microenvironment. Under near-infrared (NIR) induced thermal stimulation, MTX-TMPs could be controllably released from the low-melting-point agarose matrix hydrogel microspheres for chemotherapy (CHT) and immunotherapy (IMT). In addition, benefiting from photothermal therapy (PTT)-induced tumor immunogenic death, the anti-tumor immune response triggered by MTX-TMPs was further enhanced. Based on these features, the MTX-TMPs@MSs could remarkably eliminate tumor cells <em>in vitro</em> and obviously suppress tumor growth <em>in vivo</em> through synergistic PTT, CHT, and IMT. Therefore, it is envisaged that this TMPs-integrated microcarrier will have promising applications in clinical tumor therapy.</div></div><div><h3>Statement of Significance</h3><div>Primary liver cancer ranks third among the causes of cancer deaths globally, with hepatocellular carcinoma (HCC) being the most common type. In particular, patients with advanced HCC accompanied by malignant ascites, a common complication, indicate tumor metastasis and a poor prognosis. In this paper, we developed stimuli-responsive hydrogel microspheres from microfluidics for the delivery of methotrexate (MTX)-loaded tumor-cell-derived microparticles (MTX-TMPs) for synergistic chemotherapy, photothermal therapy, and immunotherapy. The release of MTX-TMPs from hydrogel microspheres could be on-demand controlled through BPQDs-mediated photothermal stimulus. On the other hand, BPQDs-mediated mild hyperthermia cooperatesss with MTX-TMPs-induced chemotherapy could participate in remodeling the tumor immunosuppressive microenvironment. Thus, the prepared microcarrier system holds great promise for tumor therapy.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"192 ","pages":"Pages 328-339"},"PeriodicalIF":9.4,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Black phosphorus nanoplatform coated with platelet membrane improves inhibition of atherosclerosis progression through macrophage targeting and efferocytosis 涂覆血小板膜的黑磷纳米平台通过巨噬细胞靶向和efferocytosis改善动脉粥样硬化进展的抑制作用。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-01-15 DOI: 10.1016/j.actbio.2024.11.041
Jiahui Zhang , Zhiwen Wang , Yuhan Liao , Junran Tong , Ran Gao , Zhuanglin Zeng , Yu Bai , Yumiao Wei , Xiaopeng Guo
Plaque rupture in atherosclerosis (AS) is a major cause of acute cardiovascular events. Macrophage-induced inflammatory responses and accumulation of excess reactive oxygen species (ROS) primarily induce unstable plaques. Therefore, targeting ROS clearance and functional modulation of macrophages are clinically crucial for improving plaque stability and inhibiting AS progression. Here, we constructed a bionic nano-delivery platform, PBP@siR@PM, using platelet membranes (PM) coated with black phosphorus nanosheets (BPNSs) to target macrophages in atherosclerotic plaques. Meanwhile, PM-coated BPNSs (PBP@siR@PM) were used to deliver small interfering RNA silencing Ca2+/calmodulin-dependent protein kinase γ (CaMKIIγ) into macrophages. Furthermore, macrophage efferocytosis was restored by inhibiting CaMKIIγ and increasing the expression of MerTK, a cytosolic receptor, thus promoting the clearance of apoptotic cells from plaques. This study demonstrated that intraplaque macrophage-targeted therapy using the bionic nano-delivery platform PBP@siR@PM effectively removed excess ROS from macrophages, promoted efferocytosis, cleared apoptotic cells in plaques, improved plaque stability, and largely inhibited AS progression in ApoE–/– mice after high fat diet. In summary, this study proposes a therapeutic strategy for AS and highlights the outstanding therapeutic potential of biomimetic nanomaterials in this type of chronic inflammatory disease.

Statement of significance

Rupture of atherosclerotic unstable plaques is a major cause of acute cardiovascular events. Macrophage-induced chronic inflammation and oxidative stress due to overloaded ROS are major contributors to plaque rupture. In this study, we focused on the improvement of macrophage efferocytosis within the plaque for the effective treatment of atherosclerosis. A bionic nano-delivery platform was constructed using platelet membranes (PM) coated black phosphorus nanosheets (BPNSs) to target macrophages in atherosclerotic plaques. In conclusion, intraplaque macrophage-targeted therapy based on the bionic nano-delivery platform PBP@siR@PM effectively scavenges overloaded ROS in macrophages, promotes efferocytosis, removes apoptotic cells from plaques, and improves plaque stability, which significantly inhibits the progression of atherosclerosis in ApoE–/– mice after a high-fat diet.
动脉粥样硬化(AS)斑块破裂是急性心血管事件的主要原因。巨噬细胞诱导的炎症反应和过量活性氧(ROS)的积累主要诱导不稳定斑块。因此,靶向ROS清除和巨噬细胞功能调节在临床上对于改善斑块稳定性和抑制AS进展至关重要。在这里,我们构建了一个仿生纳米递送平台PBP@siR@PM,利用涂有黑磷纳米片(BPNSs)的血小板膜(PM)靶向动脉粥样硬化斑块中的巨噬细胞。同时,pm包被的BPNSs (PBP@siR@PM)被用于将小干扰RNA沉默Ca2+/钙调素依赖性蛋白激酶γ (CaMKIIγ)递送到巨噬细胞。此外,通过抑制CaMKIIγ和增加胞质受体MerTK的表达,巨噬细胞的efferocytosis得以恢复,从而促进斑块中凋亡细胞的清除。本研究表明,采用仿生纳米递送平台PBP@siR@PM的斑块内巨噬细胞靶向治疗可有效去除巨噬细胞中过量的ROS,促进efferocytosis,清除斑块中的凋亡细胞,提高斑块稳定性,并在很大程度上抑制ApoE-/-小鼠高脂饮食后AS的进展。总之,本研究提出了一种治疗AS的策略,并强调了仿生纳米材料在这类慢性炎症性疾病中的突出治疗潜力。意义声明:动脉粥样硬化不稳定斑块破裂是急性心血管事件的主要原因。巨噬细胞引起的慢性炎症和氧化应激是导致斑块破裂的主要原因。在本研究中,我们着眼于改善斑块内巨噬细胞的efferocytosis以有效治疗动脉粥样硬化。利用血小板膜(PM)包被黑磷纳米片(BPNSs)构建了靶向动脉粥样硬化斑块巨噬细胞的仿生纳米递送平台。综上所述,基于仿生纳米递送平台PBP@siR@PM的斑块内巨噬细胞靶向治疗可有效清除巨噬细胞中超载的ROS,促进efferocytosis,清除斑块中的凋亡细胞,提高斑块稳定性,显著抑制ApoE-/-小鼠高脂饮食后动脉粥样硬化的进展。
{"title":"Black phosphorus nanoplatform coated with platelet membrane improves inhibition of atherosclerosis progression through macrophage targeting and efferocytosis","authors":"Jiahui Zhang ,&nbsp;Zhiwen Wang ,&nbsp;Yuhan Liao ,&nbsp;Junran Tong ,&nbsp;Ran Gao ,&nbsp;Zhuanglin Zeng ,&nbsp;Yu Bai ,&nbsp;Yumiao Wei ,&nbsp;Xiaopeng Guo","doi":"10.1016/j.actbio.2024.11.041","DOIUrl":"10.1016/j.actbio.2024.11.041","url":null,"abstract":"<div><div>Plaque rupture in atherosclerosis (AS) is a major cause of acute cardiovascular events. Macrophage-induced inflammatory responses and accumulation of excess reactive oxygen species (ROS) primarily induce unstable plaques. Therefore, targeting ROS clearance and functional modulation of macrophages are clinically crucial for improving plaque stability and inhibiting AS progression. Here, we constructed a bionic nano-delivery platform, PBP@siR@PM, using platelet membranes (PM) coated with black phosphorus nanosheets (BPNSs) to target macrophages in atherosclerotic plaques. Meanwhile, PM-coated BPNSs (PBP@siR@PM) were used to deliver small interfering RNA silencing Ca<sup>2+</sup>/calmodulin-dependent protein kinase γ (CaMKIIγ) into macrophages. Furthermore, macrophage efferocytosis was restored by inhibiting CaMKIIγ and increasing the expression of MerTK, a cytosolic receptor, thus promoting the clearance of apoptotic cells from plaques. This study demonstrated that intraplaque macrophage-targeted therapy using the bionic nano-delivery platform PBP@siR@PM effectively removed excess ROS from macrophages, promoted efferocytosis, cleared apoptotic cells in plaques, improved plaque stability, and largely inhibited AS progression in ApoE<sup>–/–</sup> mice after high fat diet. In summary, this study proposes a therapeutic strategy for AS and highlights the outstanding therapeutic potential of biomimetic nanomaterials in this type of chronic inflammatory disease.</div></div><div><h3>Statement of significance</h3><div>Rupture of atherosclerotic unstable plaques is a major cause of acute cardiovascular events. Macrophage-induced chronic inflammation and oxidative stress due to overloaded ROS are major contributors to plaque rupture. In this study, we focused on the improvement of macrophage efferocytosis within the plaque for the effective treatment of atherosclerosis. A bionic nano-delivery platform was constructed using platelet membranes (PM) coated black phosphorus nanosheets (BPNSs) to target macrophages in atherosclerotic plaques. In conclusion, intraplaque macrophage-targeted therapy based on the bionic nano-delivery platform PBP@siR@PM effectively scavenges overloaded ROS in macrophages, promotes efferocytosis, removes apoptotic cells from plaques, and improves plaque stability, which significantly inhibits the progression of atherosclerosis in ApoE<sup>–/–</sup> mice after a high-fat diet.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"192 ","pages":"Pages 377-393"},"PeriodicalIF":9.4,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D printing of stiff, tough, and ROS-scavenging nanocomposite hydrogel scaffold for in situ corneal repair 3D打印用于角膜原位修复的坚硬、坚韧和清除活性氧的纳米复合水凝胶支架。
IF 9.4 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2025-01-15 DOI: 10.1016/j.actbio.2024.12.005
Tan Li , Xiaoyu Zhang , Li Ma , Xia Qi , Hongwei Wang , Qingjun Zhou , Xiuli Sun , Fuyan Wang , Long Zhao , Weiyun Shi
Despite significant advancements in hydrogels in recent years, their application in corneal repair remains limited by several challenges, including unfitted curvatures, inferior mechanical properties, and insufficient reactive oxygen species (ROS)-scavenging activities. To address these issues, this study introduces a 3D-printed corneal scaffold with nanocomposite hydrogel consisting of gelatin methacrylate (GelMA), poly (ethylene glycol) diacrylate (PEGDA), Laponite, and dopamine. GelMA and PEGDA act as matrix materials with photo-crosslinking abilities. As a two-dimensional nanoclay, Laponite enhances the rheological properties of the hydrogel, making it suitable for 3D printing. Dopamine self-polymerizes into polydopamine (PDA), providing the hydrogel with ROS-scavenging activity. The incorporation of Laponite and the synergistic effect of PDA endow the hydrogel with good mechanical properties. In vitro investigations demonstrated the cytocompatibility of GelMA-PEGDA-Laponite-dopamine (GPLD) hydrogel and its ROS-scavenging activity. Furthermore, in vivo experiments using a rabbit model of lamellar keratoplasty showed accelerated corneal re-epithelialization and complete stromal repair after the implantation of the 3D-printed scaffold. Overall, due to its high bioactivity and simple preparation, the 3D-printed scaffold using GPLD hydrogel offers an alternative for corneal repair with potential for clinical translation.

Statement of Significance

The clinical application of hydrogel corneal scaffolds has been constrained by their inadequate mechanical properties and the complex microenvironment created by elevated levels of ROS post-transplantation. In this study, we developed a kind of nanocomposite hydrogel by integrating Laponite and dopamine into GelMA and PEGDA. This advanced hydrogel was utilized to 3D print a corneal scaffold with high mechanical strength and ROS-scavenging abilities. When applied to a rabbit model of lamellar keratoplasty, the 3D-printed scaffold enabled complete re-epithelialization of the cornea within one week. Three months after surgery, the corneal stroma was fully repaired, and regeneration of corneal nerve fibers was also observed. This 3D-printed scaffold demonstrated exceptional efficacy in repairing corneal defects with potential for clinical translation.
尽管近年来水凝胶在角膜修复方面取得了重大进展,但它们在角膜修复中的应用仍然受到一些挑战的限制,包括不拟合的曲率、较差的机械性能和活性氧(ROS)清除能力不足。为了解决这些问题,本研究引入了一种3d打印角膜支架,其纳米复合水凝胶由明胶甲基丙烯酸酯(GelMA)、聚乙二醇二丙烯酸酯(PEGDA)、拉脱石和多巴胺组成。GelMA和PEGDA作为具有光交联能力的基体材料。作为一种二维纳米粘土,拉脱土增强了水凝胶的流变性能,使其适合3D打印。多巴胺自聚合成聚多巴胺(PDA),使水凝胶具有清除ros的活性。拉土的掺入和PDA的协同作用使水凝胶具有良好的力学性能。体外实验证明了gelma - pegda - laponte -多巴胺(GPLD)水凝胶的细胞相容性及其清除ros的活性。此外,使用兔板层角膜移植术模型的体内实验显示,植入3d打印支架后,角膜再上皮化加速,基质修复完全。总体而言,由于其高生物活性和制备简单,使用GPLD水凝胶的3d打印支架为角膜修复提供了一种替代方案,具有临床转化的潜力。意义声明:水凝胶角膜支架的临床应用一直受到其机械性能不足和移植后活性氧(ROS)水平升高造成的复杂微环境的限制。在本研究中,我们将Laponite和多巴胺整合到GelMA和PEGDA中,制备了一种纳米复合水凝胶。这种先进的水凝胶被用于3D打印具有高机械强度和ros清除能力的角膜支架。当应用于兔板层角膜移植术模型时,3d打印支架在一周内使角膜完全重新上皮化。术后3个月,角膜基质完全修复,角膜神经纤维再生。这种3d打印支架在修复角膜缺陷方面表现出卓越的功效,具有临床转化的潜力。
{"title":"3D printing of stiff, tough, and ROS-scavenging nanocomposite hydrogel scaffold for in situ corneal repair","authors":"Tan Li ,&nbsp;Xiaoyu Zhang ,&nbsp;Li Ma ,&nbsp;Xia Qi ,&nbsp;Hongwei Wang ,&nbsp;Qingjun Zhou ,&nbsp;Xiuli Sun ,&nbsp;Fuyan Wang ,&nbsp;Long Zhao ,&nbsp;Weiyun Shi","doi":"10.1016/j.actbio.2024.12.005","DOIUrl":"10.1016/j.actbio.2024.12.005","url":null,"abstract":"<div><div>Despite significant advancements in hydrogels in recent years, their application in corneal repair remains limited by several challenges, including unfitted curvatures, inferior mechanical properties, and insufficient reactive oxygen species (ROS)-scavenging activities. To address these issues, this study introduces a 3D-printed corneal scaffold with nanocomposite hydrogel consisting of gelatin methacrylate (GelMA), poly (ethylene glycol) diacrylate (PEGDA), Laponite, and dopamine. GelMA and PEGDA act as matrix materials with photo-crosslinking abilities. As a two-dimensional nanoclay, Laponite enhances the rheological properties of the hydrogel, making it suitable for 3D printing. Dopamine self-polymerizes into polydopamine (PDA), providing the hydrogel with ROS-scavenging activity. The incorporation of Laponite and the synergistic effect of PDA endow the hydrogel with good mechanical properties. In vitro investigations demonstrated the cytocompatibility of GelMA-PEGDA-Laponite-dopamine (GPLD) hydrogel and its ROS-scavenging activity. Furthermore, in vivo experiments using a rabbit model of lamellar keratoplasty showed accelerated corneal re-epithelialization and complete stromal repair after the implantation of the 3D-printed scaffold. Overall, due to its high bioactivity and simple preparation, the 3D-printed scaffold using GPLD hydrogel offers an alternative for corneal repair with potential for clinical translation.</div></div><div><h3>Statement of Significance</h3><div>The clinical application of hydrogel corneal scaffolds has been constrained by their inadequate mechanical properties and the complex microenvironment created by elevated levels of ROS post-transplantation. In this study, we developed a kind of nanocomposite hydrogel by integrating Laponite and dopamine into GelMA and PEGDA. This advanced hydrogel was utilized to 3D print a corneal scaffold with high mechanical strength and ROS-scavenging abilities. When applied to a rabbit model of lamellar keratoplasty, the 3D-printed scaffold enabled complete re-epithelialization of the cornea within one week. Three months after surgery, the corneal stroma was fully repaired, and regeneration of corneal nerve fibers was also observed. This 3D-printed scaffold demonstrated exceptional efficacy in repairing corneal defects with potential for clinical translation.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"192 ","pages":"Pages 189-205"},"PeriodicalIF":9.4,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Biomaterialia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1